Correlation between the expressions of CARMA1 gene and MUM1 and its significance in diffuse large B cell lymphoma.
- Author:
Yu-mei CHEN
1
;
Wen-xiu YANG
;
Qing MENG
;
Yu ZHONG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Aged, 80 and over; CARD Signaling Adaptor Proteins; genetics; metabolism; Chromosomal Proteins, Non-Histone; genetics; metabolism; Female; Guanylate Cyclase; genetics; metabolism; Humans; Lymphoma, Large B-Cell, Diffuse; genetics; metabolism; pathology; Male; Middle Aged; Multiple Myeloma; genetics; metabolism; pathology; Neoplasm Staging; Young Adult
- From: Chinese Journal of Hematology 2011;32(4):236-240
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo determine the correlation between the expression of CARMA1 mRNA and MUM1 protein, as well as its effects on clinicopathological features and prognosis of diffuse large B cell lymphoma (DLBCL).
METHODSThe immunophenotype (CD20, CD79a, CD10, MUM1, Bcl6) and proliferation index of DLBCL cells were examined by immunohistochemistry (IHC). CARMA1 mRNA was detected by RT-PCR.
RESULTSCARMA1 mRNA was detected in 76 of 89 (85.40%) cases with DLBCL. The level of CARMA1 mRNA was higher in MUM1-postive group than in MUM1-negative group. No correlation was found in the expression intensity between the two molecules (P = 0.084). Ki67 positive rate was higher in MUM1(+) cases than in MUM1(-) ones (P = 0.030). There was no difference between MUM1(+) and MUM1(-) cases in sex, median age, staging, primary site and other clinicopathological features. In 58 CARMA1 mRNA positive cases, low expression cases showed more in earlier stage and more males. No difference in survival status was identified between cases with and without MUM1 expression, over- and low-expression of CARMA1 mRNA, as well as over- and low-expression of CARMA1 mRNA among 58 cases with MUM1 expression.
CONCLUSIONThe expression of CARMA1 mRNA is likely associated with the expression of MUM1 and shows male predominance in DLBCL. The expression of CARMA1 may be involved with pathogenesis and progression of ABC-like DLBCL. The two molecules correlated somewhat with some clinicopathological features, but not with survival of DLBCL.
